FDA Import Refusal BNI-0071118-2/181/1C — Letap Pharmaceuticals Ltd.
The FDA refused shipment BNI-0071118-2/181/1C from Letap Pharmaceuticals Ltd. (Ghana) on Nov 1, 2018. The refused product falls under Drugs and Biologics — AMPICILLIN (PENICILLIN, SYNTHETICALLY PRODUCED). Cited charges: 118,16,3280,336,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 1, 2018
- Country
- Ghana
- Product Category
- Drugs and Biologics
- Product Code
- 56BBA05 AMPICILLIN (PENICILLIN, SYNTHETICALLY PRODUCED)
- Charges
- 118,16,3280,336,75